Edwards Lifesciences Corp

EW

Company Profile

  • Business description

    Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.

  • Contact

    One Edwards Way
    IrvineCA92614
    USA

    T: +1 949 250-2500

    E: [email protected]

    https://www.edwards.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Devices

    Fiscal Year End

    31 December 2025

    Employees

    15,800

Edwards Lifesciences Corp News & Analysis

personal-finance

US stock market outlook: tariffs are 2025's wild card

Macrodynamic tailwinds persist, but stocks are already priced to perfection. Will tariffs derail the market in 2025?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,963.5029.200.33%
CAC 407,882.3047.720.61%
DAX 4024,281.9864.480.27%
Dow JONES (US)44,901.92208.010.47%
FTSE 1009,129.469.150.10%
HKSE25,562.13173.780.68%
NASDAQ21,108.3250.360.24%
Nikkei 22540,998.27457.96-1.10%
NZX 50 Index12,910.7457.280.45%
S&P 5006,388.6425.290.40%
S&P/ASX 2008,697.7030.800.36%
SSE Composite Index3,597.944.280.12%

Market Movers